Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC17A5 | Q9NRA2 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | MDM2 | Q00987 | 5/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 3/20 | 0.43 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | TLR2 | O60603 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5622852 | 0.86 | SLC17A5 (0.64) | SLC17A5MEN1KMT2AMDM2KDM4E | |
| SCHEMBL5622471 | 0.86 | SLC17A5 (0.64) | SLC17A5MEN1KMT2AMDM2KDM4E | |
| SCHEMBL5276812 | 0.86 | SLC17A5 (0.64) | SLC17A5MEN1KMT2AMDM2KDM4E | |
| SCHEMBL20357069 | 0.80 | NPC1 (0.52) | MDM2KDM4EALDH1A1HPGDCA12 | |
| SCHEMBL20370187 | 0.80 | NPC1 (0.52) | MDM2KDM4EALDH1A1HPGDCA12 | |
| SCHEMBL21981235 | 0.77 | MEN1 (0.61) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL21981236 | 0.77 | MEN1 (0.61) | MEN1KMT2AKDM4EALDH1A1HPGD | |
| SCHEMBL13311696 | 0.77 | TLR2 (0.61) | KMT2AMDM2TLR2 | |
| SCHEMBL12647474 | 0.77 | SLC17A5 (0.78) | SLC17A5MEN1KMT2AMDM2KDM4E | |
| SCHEMBL20281115 | 0.77 | SLC17A5 (0.61) | SLC17A5MEN1KMT2AMDM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260048134-A1 | PEPTIDE-BASED DELIVERY AGENT AND METHOD OF MAKING AND USING THE SAME | ENDOREL BIOSCIENCES LLC (US) | 2026-02-19 | — | — | US | disclosed |
| US-20260036595-A1 | STRUCTURE-BASED PEPTIDES FOR DETECTION OF TRANSTHYRETIN AMYLOID FIBRILS AND AGGREGATES IN PREECLAMPSIA | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2026-02-05 | — | — | US | disclosed |
| US-20250362310-A1 | STRUCTURE-BASED PROBE FOR DETECTION OF TRANSTHYRETIN AMYLOID FIBRILS AND AGGREGATES | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2025-11-27 | — | — | US | disclosed |
| US-20250250569-A1 | PEPTIDE-BASED DELIVERY AGENT WITH ASPARAGINE-CONTAINING MASK PEPTIDE GROUP AND METHOD OF MAKING AND USING THE SAME | ENDOREL BIOSCIENCES LLC (US) | 2025-08-07 | — | — | US | disclosed |
| EP-4568707-A1 | PEPTIDE-BASED DELIVERY AGENT AND METHOD OF MAKING AND USING THE SAME | EndoRel Biosciences LLC (US) | 2025-06-18 | — | — | EP | disclosed |
| CN-120076830-A | Peptide-based delivery agents and methods of making and using the same | 恩多雷尔生物科学有限责任公司 | 2025-05-30 | — | — | CN | disclosed |
| WO-2024036315-A1 | PEPTIDE-BASED DELIVERY AGENT AND METHOD OF MAKING AND USING THE SAME | ENDOREL BIOSCIENCES LLC (US) | 2024-02-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048134-A1 | PEPTIDE-BASED DELIVERY AGENT AND METHOD OF MAKING AND USING THE SAME | FABP1, LAMP1, SLC7A1 | SLC17A5 440/4885MEN1 1633/4885KMT2A 2388/4885 |
| US-20250250569-A1 | PEPTIDE-BASED DELIVERY AGENT WITH ASPARAGINE-CONTAINING MASK PEPTIDE GROUP AND METHOD OF MAKING AND USING THE SAME | LNPEP, ASNS, DNPEP | SLC17A5 779/4885MEN1 930/4885KMT2A 4087/4885 |
| US-20260036595-A1 | STRUCTURE-BASED PEPTIDES FOR DETECTION OF TRANSTHYRETIN AMYLOID FIBRILS AND AGGREGATES IN PREECLAMPSIA | TTR, APP, SERPINA3 | SLC17A5 885/4885MEN1 1531/4885KMT2A 4282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.